Robert LeBoyer
Stock Analyst at Noble Capital Markets
(1.01)
# 2135
Out of 5,370 analysts
20
Total ratings
46.67%
Success rate
15.68%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceutical... | Reiterates: Outperform | 70 70 | 36.37 | 92.47% | 2 | Mar 20, 2025 | |
NTRB Nutriband | Initiates Coverage On: Outperform | 13 | 7.78 | 67.1% | 1 | Jan 22, 2025 | |
GOVX Geovax Labs | Maintains: Outperform | 6 10 | 1.25 | 700% | 2 | Aug 19, 2024 | |
UNCY Unicycive Therapeuti... | Initiates Coverage On: Outperform | 6 | 0.69 | 769.57% | 1 | Feb 14, 2024 | |
CVKD Cadrenal Therapeutic... | Initiates Coverage On: Outperform | 60 | 13.54 | 343.13% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 2.81 | 255.87% | 1 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | 1.74 | 704.6% | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.84 | 852.38% | 2 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | n/a | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 8.58 | 39.86% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 825000 | n/a | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 3.06 | 390.2% | 2 | Mar 8, 2018 |